Longitudinal course of cognitive impairment in patients with atopic dermatitis
- PMID: 36708375
- DOI: 10.1007/s00403-023-02536-2
Longitudinal course of cognitive impairment in patients with atopic dermatitis
Abstract
Atopic dermatitis (AD) is a common inflammatory skin disease. Cognitive dysfunction was recently demonstrated to be increased in adults and children with AD. However, little is known about the longitudinal course of cognitive impairment in AD and its relationship with pruritus. To investigate the longitudinal course and predictors of cognitive impairment in AD a prospective dermatology practice-based study was performed using questionnaires and evaluation by a dermatologist (n = 210). Patients with ≥ 2 visits were included (mean follow-up time: 318 days). Cognitive function was assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive Function 8-item Short-Form. At baseline, 20.85% of patients had PROMIS T scores ≤ 45, indicating cognitive impairment (CI). Among patients with CI at baseline, 34.09% had persistent CI, 47.72% had a fluctuating course, and 18.18% had sustained improvement of cognitive function. In repeated-measures regression models, cognitive function scores declined overtime in patients with worse AD severity [SCORing Atopic Dermatitis (SCORAD): p = 0.01, Atopic Dermatitis Severity Index: p = 0.001], increased itch (p = 0.01), skin pain (p = 0.001), and sleep disturbance (p = 0.001). In multivariable logistic regression models, persistent CI was associated with female gender and depressive symptoms [moderate-to-severe Patient Health Questionnaire-9 score (PHQ9)]. Latent class analysis identified two classes of cognitive dysfunction: normal cognition (77.23%), moderate dysfunction (16.21%) and severe impairment (6.55%). Black/African-American race (p = 0.02), moderate-to-severe SCORAD (p = 0.03), dermatology life quality index (p < 0.0001), PHQ9 (p < 0.0001), itch (p = 0.02) and skin pain (p < 0.0001) were more likely to experience moderate dysfunction or severe cognitive impairment. AD is associated with a heterogeneous longitudinal course of cognitive function in adults, with some patients experiencing persistent CI over time.
Keywords: Atopic dermatitis; Cognitive dysfunction, learning and memory; Depression; Eczema; Emotional; Longitudinal; Prospective; Pruritus; Psychology.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Association of atopic dermatitis severity with cognitive function in adults.J Am Acad Dermatol. 2020 Nov;83(5):1349-1359. doi: 10.1016/j.jaad.2020.05.041. Epub 2020 May 16. J Am Acad Dermatol. 2020. PMID: 32428607
-
Longitudinal course and phenotypes of health-related quality of life in adults with atopic dermatitis.Clin Exp Dermatol. 2022 Feb;47(2):359-372. doi: 10.1111/ced.14948. Epub 2021 Nov 10. Clin Exp Dermatol. 2022. PMID: 34623642
-
Prevalence and associations of fatigue in childhood atopic dermatitis: A cross-sectional study.J Eur Acad Dermatol Venereol. 2023 Apr;37(4):763-771. doi: 10.1111/jdv.18819. Epub 2023 Jan 4. J Eur Acad Dermatol Venereol. 2023. PMID: 36541250 Free PMC article.
-
Patient-reported outcome (PRO) instruments for disease severity and quality of life in patients with atopic dermatitis: a systematic review of English and Chinese literature.Ann Transl Med. 2022 Aug;10(16):906. doi: 10.21037/atm-22-3164. Ann Transl Med. 2022. PMID: 36111032 Free PMC article. Review.
-
Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review.Curr Med Res Opin. 2021 Aug;37(8):1295-1301. doi: 10.1080/03007995.2021.1933929. Epub 2021 Jun 11. Curr Med Res Opin. 2021. PMID: 34027753
Cited by
-
Atopic dermatitis and cognitive dysfunction in middle-aged and older adults: A systematic review and meta-analysis.PLoS One. 2023 Oct 25;18(10):e0292987. doi: 10.1371/journal.pone.0292987. eCollection 2023. PLoS One. 2023. PMID: 37878635 Free PMC article.
-
Sleep Efficiency and Neurocognitive Decline in Atopic Dermatitis: A Systematic Review.Acta Derm Venereol. 2024 Oct 30;104:adv40459. doi: 10.2340/actadv.v104.40459. Acta Derm Venereol. 2024. PMID: 39474675 Free PMC article.
References
-
- Silverberg J, Garg N, Silverberg NB (2014) New developments in comorbidities of atopic dermatitis. Cutis 93(5):222–224 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials